Best hair loss treatment in Brasília: exosomes, PRP or transplant?
Androgenetic alopecia and diffuse thinning respond differently to each modality. Stage, cause and follicular reserve — not the treatment name — determine which approach is clinically appropriate for each patient.
Book ConsultationWhich treatment is clinically appropriate — and for whom?
The "best" hair loss treatment is the one matched to stage, cause and follicular reserve — not the most advanced technology or the most discussed brand. Exosomes, PRP and surgical transplant occupy distinct positions in the treatment hierarchy, and conflating them produces neither good clinical reasoning nor good patient outcomes.
For patients with viable follicles — detectable activity on trichoscopy or trichogram — regenerative protocols are the primary non-surgical option. Exosome-based treatment, delivered here as the Exocube capilar protocol, delivers concentrated growth-factor signalling directly to the perifollicular environment. The mechanism is biological: exosomes are extracellular vesicles that carry messenger RNA, microRNA and proteins capable of modulating follicular cycling and reducing miniaturisation. Unlike platelet-rich plasma (PRP), which concentrates autologous growth factors from the patient's own blood, exosome preparations (where cleared for clinical use) offer a more reproducible and standardised active payload.
PRP has an established evidence base endorsed by the International Society of Hair Restoration Surgery (ISHRS) and referenced in AAD clinical summaries. It remains a sound option, particularly when reproducibility of the active payload is less critical and cost is a consideration. Its limitation is variability: the concentration of growth factors depends on the individual patient's platelet count and the separation protocol used.
Surgical transplant — follicular unit extraction (FUE) or strip — is the appropriate answer when follicles in the affected zone are permanently exhausted. No regenerative stimulus can revive a follicle that has completed its miniaturisation cycle. Promising transplant to patients who still have responsive follicles, or regenerative protocols to patients with complete follicular exhaustion, are both clinical errors. The honest answer to "which is best?" begins with a trichoscopic assessment, not a treatment menu.
Clinical criteria: candidacy, contraindications and the role of medical therapy
Regenerative protocols — whether exosome-based or PRP — do not operate in isolation. The foundation of any hair-loss treatment plan is addressing the underlying cause: hormonal imbalance, nutritional deficiency, thyroid dysfunction, medication side-effects or chronic stress. Where androgenetic alopecia is the diagnosis, medical therapy with topical minoxidil and, where appropriate for the patient, oral finasteride or dutasteride, constitutes the clinical backbone. The ISHRS and AAD consistently position these agents as first-line; regenerative sessions are additive layers, not replacements.
Candidates for Exocube capilar or PRP protocols:
- Androgenetic alopecia, Hamilton-Norwood I–V (men) or Ludwig I–II (women), with trichoscopic evidence of follicular activity
- Telogen effluvium — acute or chronic — with scalp inflammation or impaired cycling
- Post-partum shedding with prolonged recovery
- Diffuse thinning associated with metabolic or hormonal transition (perimenopause, post-weight loss)
- Patients already on stable medical therapy seeking to enhance follicular response
Patients for whom regenerative protocols are insufficient:
- Advanced androgenetic alopecia (Hamilton-Norwood V–VII) with follicular depletion on the vertex and mid-scalp: transplant is the appropriate discussion
- Scarring alopecias (lichen planopilaris, frontal fibrosing alopecia, discoid lupus): active fibrosis destroys the follicular unit — these conditions require specialist dermatological management before any aesthetic intervention
- Patients expecting guaranteed regrowth: clinical honesty requires stating that regenerative protocols reduce progression and may improve density, but cannot promise specific regrowth volumes
For international patients accustomed to clinics in London, New York or Singapore, the clinical framing here is identical: no reputable centre promises regrowth. The distinction lies in the standardisation and biological quality of the regenerative agent used — a point where Exocube's formulation offers an advantage over variable-quality PRP preparations.
The Exocube capilar protocol: mechanism, sessions and what to expect in Brasília
The Exocube capilar protocol uses a pharmaceutical-grade exosome preparation delivered via scalp micro-injections under topical anaesthesia. The active fraction — a concentrated suspension of extracellular vesicles derived from mesenchymal stem cell lineage — targets the perifollicular microenvironment with growth-factor signalling, anti-inflammatory mediators and regulators of the Wnt/β-catenin and FGF-7 pathways implicated in follicular cycling. This is distinct from the mechanical stimulus of PRP and from the non-specific nutritional approach of older mesotherapy protocols.
The protocol typically involves three to four sessions spaced four to six weeks apart, with a maintenance session at six to twelve months depending on clinical response. The number of sessions is not fixed in advance: it is calibrated at each follow-up based on trichoscopic reassessment. Patients on concurrent minoxidil and finasteride tend to show the most consistent responses — the regenerative layer amplifies an already stable medical environment rather than compensating for an untreated one.
In terms of cost, the Exocube capilar protocol in Brasília is positioned in the R$ 2,000–5,000 per session range, which is substantially below equivalent exosome-based scalp treatments offered at clinics in Manhattan, Mayfair or Singapore. The active preparation used here is the same class of pharmaceutical-grade extracellular vesicle product employed in those centres; the cost difference reflects operative overhead and market structure in Brazil, not a difference in biological quality.
For patients who have already undergone transplant surgery — whether in Brazil or abroad — Exocube capilar sessions are a clinically rational post-transplant adjunct. Reducing perifollicular inflammation and supporting graft integration during the first twelve months post-procedure is a well-established rationale endorsed by hair-restoration surgery societies.
Patients who prefer PRP as a starting point — for cost reasons or personal preference — are not excluded. The practice offers PRP as part of the treatment ladder; the clinical discussion at consultation establishes which rung is most appropriate given the patient's current stage, concurrent therapies and treatment history.
Related reading:
Dr. Thiago Perfeito — Aesthetic & Regenerative Medicine
All Procedures
Signature Protocols
Dr. Thiago Perfeito
CRM-DF 23199 · Aesthetic and Regenerative Medicine
Physician with more than 10 years of practice in aesthetic and regenerative medicine. Master's degree in Aesthetic Medicine (2024). International training at Harvard Medical School and Mayo Clinic. Member of ASLMS, A4M, AMS, and NYAS. Practicing in Brasília, Lago Sul.
Learn about Dr. Thiago →Frequently asked questions about Hair loss treatment
-
How do exosomes compare with PRP for hair loss?
Both act on the perifollicular environment, but through different mechanisms. PRP concentrates autologous growth factors from the patient's blood — its efficacy depends on individual platelet count and the centrifugation protocol used, introducing variability between sessions and between patients. Exosome preparations deliver a standardised, cell-free fraction of extracellular vesicles that carry a defined payload of growth factors, microRNA and signalling proteins. Where follicular activity is measurable but limited, exosomes offer a more consistent biological input. PRP remains a clinically valid option, particularly where cost is a priority. The choice is made at consultation based on trichoscopic assessment and treatment history.
-
Who is a candidate for regenerative protocols vs transplant?
Regenerative protocols (Exocube capilar, PRP) require viable follicles — detectable activity on trichoscopy. They are appropriate for androgenetic alopecia at early to moderate stages, telogen effluvium, post-partum shedding and diffuse thinning associated with hormonal transition. Transplant is indicated when follicles in the affected zone are permanently exhausted — typically Hamilton-Norwood V–VII in men with vertex and mid-scalp depletion. Attempting regenerative stimulation of an area with no follicular reserve produces no clinical benefit. Trichoscopic assessment at consultation establishes which category applies.
-
How many sessions does the Exocube protocol involve?
The Exocube capilar protocol typically involves three to four initial sessions, spaced four to six weeks apart. Session count is not fixed in advance — it is calibrated at each follow-up based on trichoscopic reassessment and clinical response. Patients on stable medical therapy (minoxidil, finasteride where indicated) generally respond more consistently. A maintenance session at six to twelve months is standard after the initial series. The protocol is therefore individualised, not a fixed package — clinical response guides the plan.
-
Do I still need minoxidil or finasteride?
Yes. Medical therapy — topical minoxidil and, where clinically appropriate, oral finasteride or dutasteride — remains the first-line treatment for androgenetic alopecia per ISHRS and AAD guidance. Regenerative sessions (Exocube capilar or PRP) are additive layers on top of a stable medical foundation, not replacements for it. Patients who discontinue medical therapy expecting regenerative sessions to compensate typically see less durable results. If side-effect concerns are driving the question about finasteride, that is a separate clinical discussion — alternatives and topical formulations exist and are assessed at consultation.
-
What does treatment cost in Brasília?
The Exocube capilar protocol in Brasília is priced in the R$ 2,000–5,000 per session range; the total investment depends on the number of sessions defined at consultation based on clinical response. PRP sessions carry a lower per-session cost. For reference, equivalent exosome-based scalp protocols at clinics in Manhattan or London are priced significantly higher — the difference reflects local overhead and market structure, not a difference in the biological quality of the preparation. Prices significantly below the Brasília reference range typically indicate a lower-concentration or non-standardised preparation. The full protocol cost is outlined at the initial consultation once the treatment plan is individualised.
Discuss your hair loss case with Dr. Thiago Perfeito
Personalised care in Brasília. Trichoscopic assessment, regenerative protocols and honest clinical guidance — whether your starting point is exosomes, PRP, medical therapy or a combined approach.